Biotech News
Tensegrity Pharma Secures JPY150 million (USD0.97 Million) in Seed Funding to Advance Cachexia Drug
Tensegrity Pharma Inc., a Tokyo-based bio-startup, has secured ¥150 million in seed funding through a third-party allotment of new shares from Mitsubishi UFJ Capital Co., Ltd. This new investment brings the company’s total funding to ¥650 million, including an earlier
3 February 2025
Stay ahead of trends and best practices
